Anti-(human Oncostatin M Receptor Subunit .beta.) (human Monoclonal Kpl-716 .gamma.-chain)
Anti-(human Oncostatin M Receptor Subunit .beta.) (human Monoclonal Kpl-716 .gamma.-chain) Uses, Dosage, Side Effects, Food Interaction and all others data.
Anti-(human Oncostatin M Receptor Subunit .beta.) (human Monoclonal Kpl-716 .gamma.-chain) is under investigation in clinical trial NCT03816891 (A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Prurigo Nodularis).
| Trade Name | Anti-(human Oncostatin M Receptor Subunit .beta.) (human Monoclonal Kpl-716 .gamma.-chain) |
| Generic | Vixarelimab |
| Vixarelimab Other Names | Immunoglobulin g (234-proline,303-glutamine), anti-(human oncostatin m receptor subunit .beta.) (human monoclonal kpl-716 .gamma.-chain), disulfide with human monoclonal kpl-716 .lambda.-chain, dimer, Vixarelimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Anti-(human Oncostatin M Receptor Subunit .beta.) (human Monoclonal Kpl-716 .gamma.-chain)
